02/08/2025
We are trialling a potential investigational medication designed to prevent HSV-2 Ge***al Herpes from causing recurrences.
Why participate?
👉 Contribute to potential scientific breakthroughs
👉 Explore potential new investigational medications for HSV-2
If you are 18 - 60 years old, in good health and living with HSV-2, you may be eligible to participate.
You can be reimbursed up to $3,900 before tax for participating in this study.
Other study inclusion and exclusion criteria also apply. Our clinical trials involve an investigational drug and some study assessments.
Interested? Apply here: https://loom.ly/3Obsjic
Study Information: Quail is trialling an investigational medication that is being developed for the suppression of recurrent ge***al herpes in people with Herpes Simplex Virus Type 2 (HSV-2) infection.